{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:19:43Z","timestamp":1786997983460,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007408","name":"Medical Center, University of Pittsburgh","doi-asserted-by":"publisher","award":["P30CA047904"],"award-info":[{"award-number":["P30CA047904"]}],"id":[{"id":"10.13039\/100007408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["AI152655-01A1"],"award-info":[{"award-number":["AI152655-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["AI152677"],"award-info":[{"award-number":["AI152677"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["AI126995"],"award-info":[{"award-number":["AI126995"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.virol.2024.110192","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T22:58:37Z","timestamp":1722380317000},"page":"110192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Nef defect attenuates HIV viremia and immune dysregulation in the bone marrow-liver-thymus-spleen (BLTS) humanized mouse model"],"prefix":"10.1016","volume":"598","author":[{"given":"Shivkumar","family":"Biradar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antu","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry T.","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Samal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickolas","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Mahesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Teredesai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Castronova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"London","family":"Mussina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbie B.","family":"Mailliard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Smithgall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5153-2718","authenticated-orcid":false,"given":"Moses T.","family":"Bility","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2024.110192_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1874357920130621001","article-title":"T-cell signaling in HIV-1 infection","volume":"7","author":"Abbas","year":"2013","journal-title":"Open Virol. J."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12977-020-00515-3","article-title":"Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies","volume":"17","author":"Agarwal","year":"2020","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1570162X18666191223114019","article-title":"Small animal models for human immunodeficiency virus (HIV), hepatitis B, and tuberculosis: proceedings of an NIAID workshop","volume":"18","author":"Akkina","year":"2020","journal-title":"Curr. HIV Res."},{"issue":"7","key":"10.1016\/j.virol.2024.110192_bib4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41590-019-0416-z","article-title":"Humanized immune system mouse models: progress, challenges and opportunities","volume":"20","author":"Allen","year":"2019","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib5","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.20.1.21652","article-title":"Viral kinetics in untreated versus treated acute HIV infection in prospective cohort studies in Thailand","volume":"20","author":"Ananworanich","year":"2017","journal-title":"J. Int. AIDS Soc."},{"issue":"4","key":"10.1016\/j.virol.2024.110192_bib6","first-page":"373","article-title":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects","volume":"79","author":"Association","year":"2001","journal-title":"Bull. World Health Organ."},{"issue":"2","key":"10.1016\/j.virol.2024.110192_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.virol.2011.10.024","article-title":"ADAR1 is a novel multi targeted anti-HIV-1 cellular protein","volume":"422","author":"Biswas","year":"2012","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2796.2008.02043.x","article-title":"Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?","volume":"265","author":"Boasso","year":"2009","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1086\/315187","article-title":"Partial \"repair\" of defective NEF genes in a long-term nonprogressor with human immunodeficiency virus type 1 infection","volume":"181","author":"Carl","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.virol.2024.110192_bib10","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/1521-4141(200108)31:8<2382::AID-IMMU2382>3.0.CO;2-K","article-title":"Hck SH3 domain-dependent abrogation of Nef-induced class 1 MHC down-regulation","volume":"31","author":"Chang","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.virol.2024.110192_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00002030-199406000-00002","article-title":"Nef protein of HIV-1 has B-cell stimulatory activity","volume":"8","author":"Chirmule","year":"1994","journal-title":"AIDS"},{"issue":"21","key":"10.1016\/j.virol.2024.110192_bib12","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1128\/JVI.02621-05","article-title":"Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation","volume":"80","author":"Crotti","year":"2006","journal-title":"J. Virol."},{"issue":"5090","key":"10.1016\/j.virol.2024.110192_bib13","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.1470917","article-title":"Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene","volume":"258","author":"Daniel","year":"1992","journal-title":"Science"},{"issue":"7407","key":"10.1016\/j.virol.2024.110192_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/487293a","article-title":"Public health: towards a cure for HIV","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12981-017-0175-6","article-title":"HIV-I Nef inhibitors: a novel class of HIV-specific immune adjuvants in support of a cure","volume":"14","author":"Dekaban","year":"2017","journal-title":"AIDS Res. Ther."},{"issue":"3","key":"10.1016\/j.virol.2024.110192_bib16","first-page":"135","article-title":"Humanized mouse models of HIV infection","volume":"13","author":"Denton","year":"2011","journal-title":"AIDS Rev."},{"key":"10.1016\/j.virol.2024.110192_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep37021","article-title":"HIV-1 Nef sequesters MHC-I intracellularly by targeting early stages of endocytosis and recycling","volume":"6","author":"Dirk","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/JVI.73.1.436-443.1999","article-title":"Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1","volume":"73","author":"Dyer","year":"1999","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chembiol.2012.11.005","article-title":"Effector kinase coupling enables high-throughput screens for direct HIV-1 Nef antagonists with antiretroviral activity","volume":"20","author":"Emert-Sedlak","year":"2013","journal-title":"Chem. Biol."},{"issue":"3","key":"10.1016\/j.virol.2024.110192_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nm0302-207","article-title":"AIDS vaccine models: challenging challenge viruses","volume":"8","author":"Feinberg","year":"2002","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191613","article-title":"Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA","volume":"13","author":"Ferdin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2024.110192_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-5-84","article-title":"HIV-1 Nef: at the crossroads","volume":"5","author":"Foster","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.virol.2024.110192_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2015.11.030","article-title":"Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge","volume":"489","author":"Gabriel","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.virol.2024.110192_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1742-4690-4-66","article-title":"Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo","volume":"4","author":"Gorry","year":"2007","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1600-065X.2008.00751.x","article-title":"Abl tyrosine kinases in T-cell signaling","volume":"228","author":"Gu","year":"2009","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.virol.2024.110192_bib26","first-page":"193","article-title":"Non-human primate models for AIDS vaccine research","volume":"5","author":"Hu","year":"2005","journal-title":"Curr. Drug Targets: Infect. Disord."},{"issue":"2","key":"10.1016\/j.virol.2024.110192_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.chom.2007.03.004","article-title":"HIV-1 Nef assembles a Src family kinase-ZAP-70\/Syk-PI3K cascade to downregulate cell-surface MHC-I","volume":"1","author":"Hung","year":"2007","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.virol.2024.110192_bib28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri3262","article-title":"Towards an HIV cure: a global scientific strategy","volume":"12","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virol.2024.110192_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2014.12.033","article-title":"T cell exhaustion during persistent viral infections","volume":"479\u2013480","author":"Kahan","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virol.2024.110192_bib30","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105594","article-title":"Expression of HIV-1 pathogenesis factor NEF in CD4 T cells impairs antigen-specific B-cell function","author":"Kaw","year":"2020","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11904-010-0066-0","article-title":"Revisiting immune exhaustion during HIV infection","volume":"8","author":"Khaitan","year":"2011","journal-title":"Curr. HIV AIDS Rep."},{"issue":"3","key":"10.1016\/j.virol.2024.110192_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/intimm\/dxy081","article-title":"Thymus machinery for T-cell selection","volume":"31","author":"Kondo","year":"2019","journal-title":"Int. Immunol."},{"key":"10.1016\/j.virol.2024.110192_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ebiom.2019.03.077","article-title":"Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1","volume":"43","author":"Kristoff","year":"2019","journal-title":"EBioMedicine"},{"issue":"22","key":"10.1016\/j.virol.2024.110192_bib34","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199906033402203","article-title":"Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort","volume":"340","author":"Learmont","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"33","key":"10.1016\/j.virol.2024.110192_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure and function of the immune system in the spleen","volume":"4","author":"Lewis","year":"2019","journal-title":"Sci Immunol"},{"issue":"15","key":"10.1016\/j.virol.2024.110192_bib36","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1074\/jbc.RA120.012536","article-title":"HIV-1 Nef dimers short-circuit immune receptor signaling by activating Tec-family kinases at the host cell membrane","volume":"295","author":"Li","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.virol.2024.110192_bib37","doi-asserted-by":"crossref","first-page":"a007310","DOI":"10.1101\/cshperspect.a007310","article-title":"Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones","volume":"2","author":"Lifson","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nano.2012.05.012","article-title":"Nanomedicine applications towards the cure of HIV","volume":"9","author":"Lisziewicz","year":"2013","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.virol.2024.110192_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/COH.0b013e3282f525cf","article-title":"Treating HIV\/AIDS by reducing immune system activation: the paradox of immune deficiency and immune hyperactivation","volume":"3","author":"Lori","year":"2008","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"3","key":"10.1016\/j.virol.2024.110192_bib40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/v11030256","article-title":"Cellular HIV reservoirs and viral rebound from the lymphoid compartments of 4\u2032-ethynyl-2-fluoro-2\u2032-deoxyadenosine (EFdA)-Suppressed humanized mice","volume":"11","author":"Maidji","year":"2019","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.virol.2024.110192_bib41","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1128\/JVI.75.6.3034-3037.2001","article-title":"Activation of NFAT-dependent gene expression by Nef: conservation among divergent Nef alleles, dependence on SH3 binding and membrane association, and cooperation with protein kinase C-theta","volume":"75","author":"Manninen","year":"2001","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2024.110192_bib42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/QAI.0000000000002144","article-title":"Targeting ABL1 or ARG tyrosine kinases to restrict HIV-1 infection in primary CD4+ T-cells or in humanized NSG mice","volume":"82","author":"McCarthy","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development","volume":"10","author":"McMichael","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virol.2024.110192_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2019.00289","article-title":"CXCL13 as a biomarker of immune activation during early and chronic HIV infection","volume":"10","author":"Mehraj","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/icb.2009.82","article-title":"Nef, macrophages and B cells: a highway for evasion","volume":"88","author":"Moir","year":"2010","journal-title":"Immunol. Cell Biol."},{"issue":"17","key":"10.1016\/j.virol.2024.110192_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93684","article-title":"Pharmacologic HIV-1 Nef blockade promotes CD8 T cell-mediated elimination of latently HIV-1-infected cells in vitro","volume":"2","author":"Mujib","year":"2017","journal-title":"JCI Insight"},{"issue":"23","key":"10.1016\/j.virol.2024.110192_bib47","doi-asserted-by":"crossref","first-page":"11536","DOI":"10.1128\/JVI.00485-08","article-title":"Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism","volume":"82","author":"Muthumani","year":"2008","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2024.110192_bib48","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1172\/JCI120633","article-title":"Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV","volume":"129","author":"Niu","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"38","key":"10.1016\/j.virol.2024.110192_bib49","doi-asserted-by":"crossref","first-page":"23835","DOI":"10.1073\/pnas.2008615117","article-title":"Concanamycin A counteracts HIV-1 Nef to enhance immune clearance of infected primary cells by cytotoxic T lymphocytes","volume":"117","author":"Painter","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.virol.2024.110192_bib50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bbagen.2015.01.003","article-title":"HIV-1 Nef: a master manipulator of the membrane trafficking machinery mediating immune evasion","volume":"1850","author":"Pawlak","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"16","key":"10.1016\/j.virol.2024.110192_bib51","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.virol.2024.110192_bib52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jmb.2009.09.047","article-title":"HIV-1 Nef dimerization is required for Nef-mediated receptor downregulation and viral replication","volume":"394","author":"Poe","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.virol.2024.110192_bib53","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/1087057113513640","article-title":"Development and validation of a high-content bimolecular fluorescence complementation assay for small-molecule inhibitors of HIV-1 Nef dimerization","volume":"19","author":"Poe","year":"2014","journal-title":"J. Biomol. Screen"},{"issue":"4","key":"10.1016\/j.virol.2024.110192_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003294","article-title":"Comparison of SIV and HIV-1 genomic RNA structures reveals impact of sequence evolution on conserved and non-conserved structural motifs","volume":"9","author":"Pollom","year":"2013","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.virol.2024.110192_bib55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ni1302","article-title":"Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells","volume":"7","author":"Qiao","year":"2006","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.virol.2024.110192_bib56","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1083\/jcb.200407031","article-title":"HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail","volume":"167","author":"Roeth","year":"2004","journal-title":"J. Cell Biol."},{"issue":"7572","key":"10.1016\/j.virol.2024.110192_bib57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature15399","article-title":"HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation","volume":"526","author":"Rosa","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.virol.2024.110192_bib58","article-title":"Nef dimerization is required for antagonism of the host cell restriction factor, SERINC5","volume":"34","author":"Ryan","year":"2020","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"issue":"18","key":"10.1016\/j.virol.2024.110192_bib59","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120430","article-title":"Human immunodeficiency virus infection induces lymphoid fibrosis in the BM-liver-thymus-spleen humanized mouse model","volume":"3","author":"Samal","year":"2018","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.virol.2024.110192_bib60","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1128\/JVI.74.4.2038-2045.2000","article-title":"Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef","volume":"74","author":"Sawai","year":"2000","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2024.110192_bib61","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nri2636","article-title":"Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials","volume":"9","author":"Shedlock","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2024.110192_bib62","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1021\/acsinfecdis.9b00382","article-title":"Tight-Binding hydroxypyrazole HIV-1 nef inhibitors suppress viral replication in donor mononuclear cells and reverse nef-mediated MHC-I downregulation","volume":"6","author":"Shi","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"7","key":"10.1016\/j.virol.2024.110192_bib63","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1074\/jbc.M116.770016","article-title":"Cell-based fluorescence complementation reveals a role for HIV-1 nef protein dimerization in AP-2 adaptor recruitment and CD4 Co-receptor down-regulation","volume":"292","author":"Shu","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/imm.12906","article-title":"A Hitchhiker's guide to humanized mice: new pathways to studying viral infections","volume":"154","author":"Skelton","year":"2018","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.virol.2024.110192_bib65","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1016\/j.ddtec.2013.07.002","article-title":"Small molecule inhibitors of the HIV-1 virulence factor, Nef","volume":"10","author":"Smithgall","year":"2013","journal-title":"Drug Discov. Today Technol."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.179.1.115","article-title":"The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes","volume":"179","author":"Spina","year":"1994","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.virol.2024.110192_bib67","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections","volume":"83","author":"Stacey","year":"2009","journal-title":"J. Virol."},{"issue":"46","key":"10.1016\/j.virol.2024.110192_bib68","doi-asserted-by":"crossref","first-page":"15540","DOI":"10.1074\/jbc.RA120.014668","article-title":"Nef homodimers down-regulate SERINC5 by AP-2-mediated endocytosis to promote HIV-1 infectivity","volume":"295","author":"Staudt","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.virol.2024.110192_bib69","doi-asserted-by":"crossref","first-page":"15158","DOI":"10.1074\/jbc.REV120.012317","article-title":"Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes","volume":"295","author":"Staudt","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib70","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4049\/jimmunol.182.1.666","article-title":"Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4","volume":"182","author":"Struyf","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2024.110192_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.chom.2008.05.015","article-title":"Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV\/AIDS","volume":"4","author":"Swingler","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"22","key":"10.1016\/j.virol.2024.110192_bib72","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1074\/jbc.M114.572099","article-title":"The accessory factor Nef links HIV-1 to Tec\/Btk kinases in an Src homology 3 domain-dependent manner","volume":"289","author":"Tarafdar","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"37","key":"10.1016\/j.virol.2024.110192_bib73","doi-asserted-by":"crossref","first-page":"27029","DOI":"10.1074\/jbc.M601128200","article-title":"HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction","volume":"281","author":"Trible","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"37","key":"10.1016\/j.virol.2024.110192_bib74","doi-asserted-by":"crossref","first-page":"27029","DOI":"10.1074\/jbc.M601128200","article-title":"HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction","volume":"281","author":"Trible","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.virol.2024.110192_bib75","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/eji.200323682","article-title":"Vav exchange factor counteracts the HIV-1 Nef-mediated decrease of plasma membrane GM1 and NF-AT activity in T cells","volume":"33","author":"Tuosto","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2024.110192_bib76","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/aid.2013.0250","article-title":"Intracellular Nef detected in peripheral blood mononuclear cells from HIV patients","volume":"31","author":"Wang","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.virol.2024.110192_bib77","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1742-4690-10-125","article-title":"In vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis","volume":"10","author":"Watkins","year":"2013","journal-title":"Retrovirology"},{"issue":"4","key":"10.1016\/j.virol.2024.110192_bib78","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1128\/JVI.76.4.1626-1631.2002","article-title":"Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes","volume":"76","author":"Yang","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110192_bib79","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1742-4690-9-44","article-title":"Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes","volume":"9","author":"Zou","year":"2012","journal-title":"Retrovirology"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224002137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224002137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:25:49Z","timestamp":1759368349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682224002137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":79,"alternative-id":["S0042682224002137"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2024.110192","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nef defect attenuates HIV viremia and immune dysregulation in the bone marrow-liver-thymus-spleen (BLTS) humanized mouse model","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2024.110192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110192"}}